Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

Hydroxyurea-inducible SAR1 gene acts through the Giα/JNK/Jun pathway to regulate γ-globin expression.

Zhu J, Chin K, Aerbajinai W, Kumkhaek C, Li H, Rodgers GP.

Blood. 2014 Aug 14;124(7):1146-56. doi: 10.1182/blood-2013-10-534842. Epub 2014 Jun 9.

PMID:
24914133
[PubMed - in process]
Free PMC Article
2.

Emerging science of hydroxyurea therapy for pediatric sickle cell disease.

Green NS, Barral S.

Pediatr Res. 2014 Jan;75(1-2):196-204. doi: 10.1038/pr.2013.227. Epub 2013 Nov 19.

PMID:
24252885
[PubMed - in process]
Free PMC Article
3.

Information exploration system for sickle cell disease and repurposing of hydroxyfasudil.

Essack M, Radovanovic A, Bajic VB.

PLoS One. 2013 Jun 10;8(6):e65190. doi: 10.1371/journal.pone.0065190. Print 2013.

PMID:
23762313
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The association of CD81 polymorphisms with alloimmunization in sickle cell disease.

Tatari-Calderone Z, Tamouza R, Le Bouder GP, Dewan R, Luban NL, Lasserre J, Maury J, Lionnet F, Krishnamoorthy R, Girot R, Vukmanovic S.

Clin Dev Immunol. 2013;2013:937846. doi: 10.1155/2013/937846. Epub 2013 May 22.

PMID:
23762099
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

To respond or not to respond to hydroxyurea in thalassemia: a matter of stress adaptation?

Ronchi A, Ottolenghi S.

Haematologica. 2013 May;98(5):657-9. doi: 10.3324/haematol.2013.084392. No abstract available.

PMID:
23633538
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea.

Green NS, Ender KL, Pashankar F, Driscoll C, Giardina PJ, Mullen CA, Clark LN, Manwani D, Crotty J, Kisselev S, Neville KA, Hoppe C, Barral S.

PLoS One. 2013;8(2):e55709. doi: 10.1371/journal.pone.0055709. Epub 2013 Feb 7.

PMID:
23409025
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen.

Paule I, Sassi H, Habibi A, Pham KP, Bachir D, Galactéros F, Girard P, Hulin A, Tod M.

Orphanet J Rare Dis. 2011 May 28;6:30. doi: 10.1186/1750-1172-6-30.

PMID:
21619673
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Fetal hemoglobin in sickle cell anemia.

Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, Chui DH, Steinberg MH.

Blood. 2011 Jul 7;118(1):19-27. doi: 10.1182/blood-2011-03-325258. Epub 2011 Apr 13. Review.

PMID:
21490337
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease.

Green NS, Barral S.

Pediatr Blood Cancer. 2011 Feb;56(2):177-81. doi: 10.1002/pbc.22754. Epub 2010 Sep 9. Review.

PMID:
20830771
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk